Vicente Valenti - Publications

The precision of a report on precision.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 24, 2025

Bayesian selection of lipidome dynamics features for a K-nearest neighbors (KNN) classifier model of tumor response in patients with advanced gastrointestinal adenocarcinoma undergoing systemic treatment.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 05, 2025

Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial.

Journal: ESMO open

Published: September 25, 2025

Variation of Plasma Damage-Associated Molecular Patterns in Patients with Advanced Solid Tumors after Standard of Care Systemic Treatment.

Journal: Cancer investigation

Published: November 17, 2023

Streptozotocin, 1982-2022: Forty Years from the FDA's Approval to Treat Pancreatic Neuroendocrine Tumors.

Journal: Neuroendocrinology

Published: February 13, 2022

Is short-course radiotherapy and total neoadjuvant therapy the new standard of care in locally advanced rectal cancer? A sensitivity analysis of the RAPIDO clinical trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 25, 2022

Fooled by Randomness. The Misleading Effect of Treatment Crossover in Randomized Trials of Therapies with Marginal Treatment Benefit.

Journal: Cancer investigation

Published: December 17, 2021

SUNRISE-DI study. The daily sunrise is easier to predict than the benefit of adjuvant treatment in colon cancer.

Journal: ESMO open

Published: June 16, 2021

Olaratumab-induced Biomarker Modulation in Sarcomas-Letter.

Journal: Molecular cancer therapeutics

Published: May 11, 2021

Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 04, 2021

Bayesian interpretation of the ESMO guideline for localized colorectal cancer: a better IDEA.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 31, 2020

Increased survival time or better quality of life? Trade-off between benefits and adverse events in the systemic treatment of cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 19, 2019